GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ANG-PD · Jun 30, 2019

American National Group Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001039828-19-000056Insurance
Cash70thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$1.2B · CORE · VALID

Policy-benefit growth10thOwn-history percentile · N=20
Evidence method

Yoy · gp.insurance.policy_benefits

-25.19% · OPTIONAL · VALID

Net-income growth26thOwn-history percentile · N=19
Evidence method

Yoy · gp.fundamentals.net_income

-80.20% · CORE · VALID

Premium growth15thOwn-history percentile · N=20
Evidence method

Yoy · gp.insurance.premiums

-28.33% · CORE · VALID

Revenue growth50thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.revenue

3.05% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History51 statesSelf-history eligible
Period transition

What moved in the state?

Cash Increased
Previous
$1.1B
Current
$1.2B
Delta
$100.1M
Claims Growth Decreased
Previous
-23.11%
Current
-25.19%
Delta
-2.08%
Earnings Growth Increased
Previous
-121.29%
Current
-80.20%
Delta
41.09%
Premium Growth Increased
Previous
-40.24%
Current
-28.33%
Delta
11.91%
Revenue Growth Decreased
Previous
741.85%
Current
3.05%
Delta
-738.79%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.